West Pharmaceutical Services, Inc.
WST

$22.57 B
Marketcap
$311.66
Share price
Country
$7.56
Change (1 day)
$413.70
Year High
$265.00
Year Low

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

marketcap

P/E ratio for West Pharmaceutical Services, Inc. (WST)

P/E ratio as of 2023: 44.09

According to West Pharmaceutical Services, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 44.09. At the end of 2022 the company had a P/E ratio of 29.89.

P/E ratio history for West Pharmaceutical Services, Inc. from 1985 to 2023

PE ratio at the end of each year

Year P/E ratio
2023 44.09
2022 29.89
2021 52.73
2020 60.48
2019 46.03
2018 35.01
2017 48.39
2016 43.30
2015 45.35
2014 29.70
2013 30.41
2012 23.07
2011 16.94
2010 21.01
2009 17.71
2008 14.23
2007 18.78
2006 24.59
2005 17.08
2004 38.72
2003 15.40
2002 19.16
2001 -73.33
2000 221.15
1999 11.92
1998 87.52
1997 11.04
1996 28.27
1995 13.57
1994 16.18
1993 16.57
1992 17.87
1991 -33.89
1990 45.33
1989 14.84
1988 14.02
1987 19.72
1986 13.32
1985 13.60